Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity

Yi Yang1, Siqi Wang2, Jiaoyang Cai2

  • 1Pediatric Translational Medicine Institute, Department of Hematology & Oncology, Shanghai Children?s Medical Center, Shanghai Jiao Tong University School of Medicine, National Health Committee Key Laboratory of Pediatric Hematology & Oncology, Shanghai, 200127, China.

Abstract

No abstract available in PubMed .